This technology is a collection of monoclonal potent antibodies that target epitopes of SARS-CoV-2 and other coronaviruses for COVID-19 prophylaxis and therapeutic applications.

This technology is a graphene nanosensor for highly sensitive and rapid responsive measurement of real-time arginine vasopressin levels.

This technology is a graphene field-effect transistor (FET) biosensor that uses aptamer binding kinetics for rapid and reliable detection of protein biomarkers, enabling precise point-of-care diagnostics without requiring individual sensor calibration.